Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis
Therapeutic Advances in Respiratory Disease · 2024-01 · 18
DOI: 10.1177/17534666231225323 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 17.01.2024. Verfasst von Jian-Chao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: COVID-19, Noninvasive Ventilation, Respiratory Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Science and Technology of Liaoning Province, Science and Technology Planning Project.
Abstract (Originalsprache)
Background
High-flow nasal cannula (HFNC) and conventional oxygen therapy (COT) are important respiratory support strategies for acute hypoxemic respiratory failure (AHRF) in coronavirus disease 2019 (COVID-19) patients. However, the results are conflicting for the risk of intubation with HFNC as compared to COT.
Objectives
We systematically synthesized the outcomes of HFNC relative to COT in COVID-19 patients with AHRF and evaluated these outcomes in relevant subpopulations.
Design
This study was designed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources and methods: We searched PubMed, EMBASE, Web of Science, Scopus, ClinicalTrials.gov, medRxiv, BioRxiv, and the Cochrane Central Register of Controlled Trials for randomized controlled trials and observational studies that compared the efficacy of HFNC with COT in patients with COVID-19-related AHRF. Primary outcomes were intubation rate and mortality rate. Secondary outcomes were the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO 2 /FiO 2 ), respiratory rate, hospital length of stay, intensive care unit (ICU) length of stay, and days free from invasive mechanical ventilation.
Results
In total, 20 studies with 5732 patients were included. We found a decreased risk of requiring intubation in HFNC compared to COT [odds ratio (OR) = 0.61, 95% confidence interval (CI): 0.46–0.82, p = 0.0009, I 2 = 75%]. Similarly, we found HFNC was associated with lower risk of intubation rate compared to COT in the subgroup of patients with baseline PaO 2 /FiO 2 < 200 mmHg (OR = 0.69, 95% CI: 0.55–0.86, p = 0.0007, I 2 = 45%), and who were in ICU settings at enrollment (OR = 0.57, 95% CI: 0.38–0.85, p = 0.005, I 2 = 80%). HFNC was associated with an improvement of PaO 2 /FiO 2 and respiratory rate compared to COT. The use of HFNC compared to COT did not reduce the mortality rate, days free from invasive mechanical ventilation, hospital length of stay, or ICU length of stay.
Conclusion
Compared to COT, HFNC may decrease the need for tracheal intubation in patients with COVID-19-related AHRF, particularly among patients with baseline PaO 2 /FiO 2 < 200 mmHg and those in ICU settings.
Trial registration
This systematic review and meta-analysis protocol was prospectively registered with PROSPERO (no. CRD42022339072).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
- Department of Intensive Care Medicine, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Heping District, Shenyang, China.
- Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang 110001, China.
ORCID-Profile: Jian-Chao Wang, Wei Tan
Förderung
- Department of Science and Technology of Liaoning Province
- Science and Technology Planning Project
Zitieren
APA
Wang, J. C., Peng, Y., Dai, B., Hou, H. J., Zhao, H. W., Wang, W., & Tan, W. (2024). Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666231225323
Vancouver
Wang JC, Peng Y, Dai B, Hou HJ, Zhao HW, Wang W, et al. Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666231225323
BibTeX
@article{Wang2024,
author = {Wang, Jian-Chao and Peng, Yun and Dai, Bing and Hou, Hai-Jia and Zhao, Hong-Wen and Wang, Wei and Tan, Wei},
title = {Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
volume = {18},
doi = {10.1177/17534666231225323}
}
EUVIMED